Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10910797 | Lung Cancer | 2015 | 7 Pages |
Abstract
Alternatively COPD could be a driving factor in lung cancer, by increasing oxidative stress and the resulting DNA damage, chronic exposure to pro-inflammatory cytokines, repression of the DNA repair mechanisms and increased cellular proliferation. Understanding the mechanisms that drive these processes in primary cells from patients with these diseases along with better disease models is essential for the development of new treatments.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
A.L. Durham, I.M. Adcock,